{"type_of_material": "News", "print_page": 0, "_id": "58baf85895d0e024902fd8a8", "headline": {"main": "Sanofi, Regeneron Say Latest Dupixent Eczema Drug Tests Positive", "print_headline": "Sanofi, Regeneron Say Latest Dupixent Eczema Drug Tests Positive"}, "blog": [], "lead_paragraph": "Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis (AD) had been positive. ", "document_type": "article", "snippet": "Drugmakers Sanofi and Regeneron said on Saturday results from a one-year test of their Dupixent product aimed at adults with eczema or moderate-to-severe atopic dermatitis (AD) had been positive....", "section_name": "Business Day", "web_url": "https://www.nytimes.com/reuters/2017/03/04/business/04reuters-sanofi-regeneron.html", "byline": {"organization": "REUTERS", "original": "By REUTERS", "person": []}, "word_count": 136, "keywords": [], "abstract": null, "slideshow_credits": null, "subsection_name": null, "source": "Reuters", "pub_date": "2017-03-04T17:24:32+0000", "multimedia": [], "news_desk": "None"}